On May 22, 2025, Artelo Biosciences, Inc. received a notice from Nasdaq stating it does not comply with the minimum stockholders' equity requirement, reporting only $652,000 against the $2.5 million needed. The company has until July 7, 2025, to submit a plan to regain compliance and has 180 days to meet the requirement if accepted.